4//SEC Filing
ACELRX PHARMACEUTICALS INC 4
Accession 0001181431-14-012064
$TLPHCIK 0001427925operating
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 3:24 PM ET
Size
4.7 KB
Accession
0001181431-14-012064
Insider Transaction Report
Form 4
KING RICHARD
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2014-03-02$11.43/sh−11,599$132,577→ 134,567 total
Footnotes (2)
- [F1]The Shares were withheld to satisfy tax liability upon vesting 25% of the restricted stock units of the Company previously reported on March 4, 2011.
- [F2]Balance includes non-reportable acquisition of 19,209 shares of Common Stock through the Company's Employee Stock Purchase Plan.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001427925
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 3:24 PM ET
- Size
- 4.7 KB